These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23940537)

  • 1. Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.
    Klinker MW; Reed TJ; Fox DA; Lundy SK
    PLoS One; 2013; 8(8):e70131. PubMed ID: 23940537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 supports the expansion of FasL
    Wang K; Tao L; Su J; Zhang Y; Zou B; Wang Y; Zou M; Chen N; Lei L; Li X
    Mol Immunol; 2017 Jul; 87():188-199. PubMed ID: 28505514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.
    Lundy SK; Boros DL
    Infect Immun; 2002 Feb; 70(2):812-9. PubMed ID: 11796615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes.
    Lundy SK; Taitano SH; van der Vlugt LEPM
    Methods Mol Biol; 2021; 2270():149-178. PubMed ID: 33479898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.
    Lundy SK; Fox DA
    Arthritis Res Ther; 2009; 11(4):R128. PubMed ID: 19706160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and activity of Fas ligand producing CD5⁺ B cells.
    Lundy SK; Klinker MW
    Methods Mol Biol; 2014; 1190():81-102. PubMed ID: 25015275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies.
    Kondo M; Murakawa Y; Harashima N; Kobayashi S; Yamaguchi S; Harada M
    Immunology; 2009 Sep; 128(1 Suppl):e589-99. PubMed ID: 19740320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIP induces mice CD19(hi) regulatory B cells producing IL-10 and highly expressing PD-L1, FasL.
    Tang Y; Jiang Q; Ou Y; Zhang F; Qing K; Sun Y; Lu W; Zhu H; Gong F; Lei P; Shen G
    Mol Immunol; 2016 Jan; 69():44-51. PubMed ID: 26655428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Fas ligand expression of peripheral B-1 cells correlated with CD4
    Mishra R; Panda SK; Sahoo PK; Bal MS; Satapathy AK
    Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28208221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of human IgE synthesis in B cells by a basophilic cell line, KU812.
    Yanagihara Y; Kajiwara K; Basaki Y; Ikizawa K; Akiyama K; Saito H
    Clin Exp Immunol; 1997 May; 108(2):295-301. PubMed ID: 9158101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression Fas and FasL antigen protein of lymphocytes T and B in hypertrophied adenoid in children with otitis media with effusion].
    Zelazowska-Rutkowska B; Wysocka J; Ratomski K; Skotnicka B; Zak J; Mrugacz M
    Otolaryngol Pol; 2008; 62(1):59-64. PubMed ID: 18637423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of diosmetin extracted from Galium verum L. on the thymus of U14-bearing mice.
    Zhao R; Chen Z; Jia G; Li J; Cai Y; Shao X
    Can J Physiol Pharmacol; 2011 Sep; 89(9):665-73. PubMed ID: 21851214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment.
    van Rensburg IC; Kleynhans L; Keyser A; Walzl G; Loxton AG
    Immun Inflamm Dis; 2017 Mar; 5(1):57-67. PubMed ID: 28250925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of Fas and Fas ligand on peripheral blood lymphocytes in normal subjects.
    Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Koji T; Urayama S; Nakashima T; Kawabe Y; Nagataki S
    J Lab Clin Med; 1998 Nov; 132(5):404-13. PubMed ID: 9823934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.